Hugh McGuire

4.9k total citations · 2 hit papers
25 papers, 3.2k citations indexed

About

Hugh McGuire is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Hugh McGuire has authored 25 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 15 papers in Pharmacology and 8 papers in Clinical Psychology. Recurrent topics in Hugh McGuire's work include Treatment of Major Depression (15 papers), Electroconvulsive Therapy Studies (9 papers) and Schizophrenia research and treatment (5 papers). Hugh McGuire is often cited by papers focused on Treatment of Major Depression (15 papers), Electroconvulsive Therapy Studies (9 papers) and Schizophrenia research and treatment (5 papers). Hugh McGuire collaborates with scholars based in United Kingdom, Japan and Italy. Hugh McGuire's co-authors include Rachel Churchill, Corrado Barbui, Toshi A. Furukawa, Andrea Cipriani, Atsuo Nakagawa, Norio Watanabe, Ichiro M Omori, John Geddes, Michele Tansella and Georgia Salanti and has published in prestigious journals such as The Lancet, Cochrane Database of Systematic Reviews and The British Journal of Psychiatry.

In The Last Decade

Hugh McGuire

25 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

2009 1.2k citations Andrea Cipriani, Toshi A. Furukawa et al. The Lancet profile →
Treatment and prevention of mental disorders in low-income and middle-income countries

2007 629 citations Vikram Patel, Ricardo Araya et al. The Lancet profile →

Peers

Hugh McGuire

PHARM

PMH

ECP

Marcia G. Toprac United States

Jenny Guidi Italy

Antoni Serrano‐Blanco Spain

Thomas Laughren United States

Greg Freedman United States

Emmanuelle Corruble France

Ángel L. Montejo Spain

Ichiro M Omori Japan

Hannu Koponen Finland

Atsuo Nakagawa Japan

Marcia G. Toprac United States

Hugh McGuire

995 ×1.0

PHARM

949 ×0.9

1.8k ×2.2

PMH

743 ×1.2

ECP

643 ×1.1

Citations per year, relative to Hugh McGuire Hugh McGuire (= 1×) peers Marcia G. Toprac

Countries citing papers authored by Hugh McGuire

Since Specialization

Citations

This map shows the geographic impact of Hugh McGuire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh McGuire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh McGuire more than expected).

Fields of papers citing papers by Hugh McGuire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh McGuire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh McGuire. The network helps show where Hugh McGuire may publish in the future.

Co-authorship network of co-authors of Hugh McGuire

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh McGuire. A scholar is included among the top collaborators of Hugh McGuire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh McGuire. Hugh McGuire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McGuire, Hugh, et al.. (2012). Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia. Cochrane Database of Systematic Reviews. 2019(3). CD009017–CD009017. 11 indexed citations

Cipriani, Andrea, Toshi A. Furukawa, Georgia Salanti, et al.. (2009). Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. The Lancet. 373(9665). 746–758. 1166 indexed citations breakdown →

Cipriani, Andrea, Teresa La Ferla, Toshi A. Furukawa, et al.. (2009). Sertraline versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews. CD006117–CD006117. 91 indexed citations

Watanabe, Norio, Ichiro M Omori, Atsuo Nakagawa, et al.. (2009). Safety Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-Phase Treatment of Adults with Depression. CNS Drugs. 24(1). 35–53. 71 indexed citations

Churchill, Rachel, Deborah M Caldwell, Hugh McGuire, et al.. (2009). Reboxetine versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews. 5 indexed citations

Cipriani, Andrea, Toshi A. Furukawa, Alessandra Signoretti, et al.. (2009). Escitalopram versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews. 2016(5). CD006532–CD006532. 155 indexed citations

Watanabe, Norio, Ichiro M Omori, Atsuo Nakagawa, et al.. (2008). Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.. PubMed. 69(9). 1404–15. 60 indexed citations

Watanabe, Norio, Ichiro M Omori, Atsuo Nakagawa, et al.. (2008). Mirtazapine Versus Other Antidepressants in the Acute-Phase Treatment of Adults With Major Depression. The Journal of Clinical Psychiatry. 69(9). 1404–1415. 5 indexed citations

Cipriani, Andrea, Toshi A. Furukawa, John Geddes, et al.. (2008). Does Randomized Evidence Support Sertraline as First-Line Antidepressant for Adults With Acute Major Depression?. The Journal of Clinical Psychiatry. 69(11). 1732–1742. 29 indexed citations

10.

Nakagawa, Atsuo, Norio Watanabe, Ichiro M Omori, et al.. (2008). Efficacy and Tolerability of Milnacipran in the Treatment of Major Depression in Comparison with??Other Antidepressants. CNS Drugs. 22(7). 587–602. 18 indexed citations

11.

McGuire, Hugh, et al.. (2008). Psychosocial interventions for prevention of psychological disorders in law enforcement officers. Cochrane Database of Systematic Reviews. CD005601–CD005601. 54 indexed citations

12.

Watanabe, Norio, Atsuo Nakagawa, Tatsuo Akechi, et al.. (2008). Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis. Journal of Psychopharmacology. 23(5). 539–550. 25 indexed citations

13.

Okai, David, Gareth Owen, Hugh McGuire, et al.. (2007). Mental capacity in psychiatric patients. The British Journal of Psychiatry. 191(4). 291–297. 175 indexed citations

14.

Patel, Vikram, Ricardo Araya, Sudipto Chatterjee, et al.. (2007). Treatment and prevention of mental disorders in low-income and middle-income countries. The Lancet. 370(9591). 991–1005. 629 indexed citations breakdown →

15.

Cipriani, Andrea, Alessandra Signoretti, Toshi A. Furukawa, et al.. (2007). Venlafaxine versus other anti-depressive agents for depression. Cochrane Database of Systematic Reviews. 11 indexed citations

16.

Patel, Vikram, Ricardo Araya, Sudipto Chatterjee, et al.. (2007). Global Mental Health 3 Treatment and prevention of mental disorders in low-income and middle-income countries. 11 indexed citations

17.

Barbui, Corrado, Eugenio Aguglia, Davide Carlino, et al.. (2007). Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD). Cochrane Database of Systematic Reviews. CD005333–CD005333. 101 indexed citations

18.

Omori, Ichiro M, Norio Watanabe, Andrea Cipriani, et al.. (2006). Fluvoxamine versus other anti-depressive agents for depression (Protocol). 2. 1–11. 5 indexed citations

19.

Furukawa, Toshi A., Toshiya Inada, Clive E Adams, et al.. (2002). Are the Cochrane group registers comprehensive? A case study of Japanese psychiatry trials. BMC Medical Research Methodology. 2(1). 6–6. 7 indexed citations

20.

Churchill, Rachel & Hugh McGuire. (1998). Developments in the evidence base in primary care psychiatry. International Review of Psychiatry. 10(2). 143–147. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact